Resmed Inc. buy Needham & Company LLC
Start price
01.04.24
/
50%
€177.75
Target price
01.04.25
€207.72
Performance (%)
15.33%
End price
02.04.25
€205.00
Summary
This prediction ended on 02.04.25 with a price of €205.00. The BUY prediction by Needham___Company_LL finished with a performance of 15.33%. A total of €1.93 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -3.767% | -3.767% | -6.802% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten

